Home
G&W Laboratories

G&W Laboratories Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domaingwlabs.com

Year Founded1919

Employees501 - 1000

Annual Revenue$200M - $500M

G&W Laboratories

G&W Laboratories (including company regionals)

gwlabs.com

See more website traffic and engagement information

G&W Laboratories Revenue up to November 2025 is 200M - 500M

revenue generated by G&W Laboratories top domains

G&W Laboratories top domains revenue over 3 years

Revenue for G&W Laboratories top domains

gwlabs.com200M - 500M

See more with Sales Intelligence

Total visits to G&W Laboratories's top domains

Understand G&W Laboratories market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

gwlabs.com353

See more with Sales Intelligence

Avg. visit duration in G&W Laboratories's top domains

Analyze G&W Laboratories engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

gwlabs.com--

See more with Sales Intelligence

Avg. pageviews on G&W Laboratories's top domains

See how G&W Laboratories keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

gwlabs.com1.05

See more with Sales Intelligence

G&W Laboratories top competitors by domain

Top similar sites in November 2025, ranked by their affinity

genzyme.comCompany NameGenzymeEmployees> 10001HQUnited States, Massachusetts, CambridgeAnnual revenue> $1BTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by G&W Laboratories

These are the website technologies, by industry, used by G&W Laboratories top domains

Content Management System (1)

WordPress

Conversion & Analytics (1)

Google Analytics

Email Services (1)

Microsoft Exchange Online

Marketing (1)

Google Marketing Platform

More Technologies

3

See all

News & Signals from G&W Laboratories

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsG&W Laboratories, Inc. sells assets to Piramal Enterprises in the amount of $0.Piramal Enterprises (PEL) rose 1.04% to Rs 1,176.05 after the company announced acquisition of solid oral dosage drug product facility in the US from G&W Laboratories Inc.

NewsG&W Laboratories, Inc. sold assets to Piramal Pharma Solutions on May 29th '20.Piramal Pharma Solutions (PPS), the contract development and manufacturing organisation (CDMO) arm of the diversified Piramal Enterprises Ltd (PEL), has acquired a solid oral dosage drug manufacturing facility from the US-based G&W Laboratories, Inc.

NewsG&W Laboratories, Inc. invests into assets: solid oral dosage product manufacturing facility in the amount of $17M in US' Sellersville.Piramal Enterprises Ltd's pharma solutions business has entered a pact with G&W Laboratories to acquire its solid oral dosage product manufacturing facility in US' Sellersville for over Rs 130 crore.